A case of malignant fibrous histiocytoma in the maxilla
Xin-Rui Ma +3 more
doaj +1 more source
Actinomyces lesions and acute inflammation predominate in osteonecrosis of the jaw associated with osteoclast-suppressing therapy in contrast to non-medication-related osteonecrosis. [PDF]
Kivelä-Rajamäki M +6 more
europepmc +1 more source
[Effect of apernyl in the treatment of complications of surgery for jaw neoplasms].
R, Koczorowski, S, Wloch
openaire +1 more source
This review charts the evolution of cholinergic therapies for neurodegenerative diseases—from classical acetylcholinesterase inhibitors (AChEIs) providing symptomatic relief to precision multi‐target drugs and neuromodulation (VNS, DBS, NIBS) that restore dysfunctional circuits. Emerging gene therapy, cell regeneration, and advanced cholinergic imaging
Lei Lei +4 more
wiley +1 more source
Reframing the starting point of shared decision-making under algorithmic short-form video exposure: bone tumor care as a sentinel context. [PDF]
Wang JW, Feng YF, Zhang ZB.
europepmc +1 more source
[Intratracheal anesthesia in operations of jaw neoplasms].
openaire +1 more source
Taurine and Metabolic Diseases: Molecular Mechanisms and Therapeutic Implications
The dietary sources of taurine, as well as its protective effects and mechanisms in metabolism‐related diseases and metabolic disorder–associated ocular and cerebral injuries. ABSTRACT Taurine (Tau) is a sulfur‐containing amino acid prevalent in animal tissues and primarily acquired through dietary sources.
Xiaojie Ma, Zhijian Rao, Lifang Zheng
wiley +1 more source
Pathological fracture following minimal trauma as the initial presentation of parathyroid carcinoma-associated hyperparathyroidism in a young man: a case report. [PDF]
Vuksanović M +5 more
europepmc +1 more source
[Primary multiple neoplasms of the oral cavity, jaws and face].
H, Krysiak, A, Wiktor
openaire +1 more source
Langerhans Cell Histiocytosis in Adults: A Canadian Multicenter Case Series
ABSTRACT Langerhans cell histiocytosis (LCH) is a rare clonal myeloid neoplasm. Canadian data on clinical characteristics, molecular profile, and treatment outcomes is limited. This study aims to report the initial experience of a Canadian rare diseases program, reflecting “real‐world” diagnostic pathways, referral patterns, and treatment heterogeneity
Stephanie Quon +7 more
wiley +1 more source

